Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection

MLA

Zugna, D., et al. Time to Virological Failure, Treatment Change and Interruption for Individuals Treated within 12 Months of HIV Seroconversion and in Chronic Infection. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....f3aae79a780cc40bb355dc4481adb709&authtype=sso&custid=ns315887.

APA

Zugna, D., Geskus, R., De Stavola, B., Rosinska, M., Bartmeyer, B., Boufassa, F., Chaix, M., Babiker, A., Porter, K., García de Olalla P., & CASCADE Collaboration EuroCoord. (2012). Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection.

Chicago

Zugna, D, Rb Geskus, B De Stavola, M Rosinska, B Bartmeyer, F Boufassa, Ml Chaix, et al. 2012. “Time to Virological Failure, Treatment Change and Interruption for Individuals Treated within 12 Months of HIV Seroconversion and in Chronic Infection,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....f3aae79a780cc40bb355dc4481adb709&authtype=sso&custid=ns315887.